Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia

Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia

Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are hematologic malignancies arising from the bone marrow. Despite recent advances in treating these diseases, patients with higher-risk MDS and AML continue to have a poor prognosis with limited survival. It has long been recognized t...

Full description

Bibliographic Details
Main Authors:	Sargam Kapoor, Grace Champion, Aparna Basu, Anu Mariampillai, Matthew J. Olnes
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Series:	Cancers
Subjects:	acute myeloid leukemia myelodysplastic syndromes immune therapy monoclonal antibody antibody drug conjugate CAR T-cells
Online Access:	https://www.mdpi.com/2072-6694/13/19/5026

Similar Items

New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Marco Gallazzi, et al.
Published: (2022-07-01)

Inmunofenotipaje celular en el diagnostico de la leucemia mieloide aguda Cellular immunophenotyping in the diagnosis of acute myeloid leukemia
Published: (2005-12-01)

Characterisation of Myeloid, Lymphiod and Erythroid Cell Lineages in Myelodysplastics Syndrome Using Flow Cytometry
by: Broojerdi, Mohadese Hashem
Published: (2011)

Circular RNAs in Hematopoiesis with a Focus on Acute Myeloid Leukemia and Myelodysplastic Syndrome
by: Michaela Dostalova Merkerova, et al.
Published: (2020-08-01)

Transformation of a myelodysplastic syndrome to acute myeloid leukemia and concurrent necrotizing sweet syndrome
by: Olga Vera-Lastra, et al.
Published: (2021-03-01)

Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience
by: İbrahim Ethem Pınar, et al.
Published: (2021-03-01)

Association of loss of heterozygosity with cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome
by: R.F. Pinheiro, et al.
Published: (2008-07-01)

Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Georgios Petros Barakos, et al.
Published: (2022-06-01)

Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
by: Huai-Hsuan Huang, et al.
Published: (2019-06-01)

Therapy related acute myeloid leukemia with t(10:16): a rare entity
by: Guldeep K. Uppal, et al.
Published: (2011-12-01)

Editorial: Uncovering the relationship between myelodysplastic syndromes and acute myeloid leukemia
by: Mohamed A. Yassin, et al.
Published: (2023-01-01)

Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Yasmin Abaza, et al.
Published: (2022-07-01)

Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
by: Vincent G. Sorrentino, et al.
Published: (2021-07-01)

Immunotherapy in Acute Myeloid Leukemia: Where We Stand
by: Alessandro Isidori, et al.
Published: (2021-05-01)

Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia
by: S V Gritsaev, et al.
Published: (2016-07-01)

Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies
by: Uwe Platzbecker, et al.
Published: (2022-05-01)

Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: concomitant occurrence of two molecularly distinct diseases
by: Yenny Alejandra Moreno Vanegas, et al.
Published: (2018-09-01)

The efficacy and safety of venetoclax and azacytidine combination treatment in patients with acute myeloid leukemia and myelodysplastic syndrome: systematic review and meta-analysis
by: Yufeng Du, et al.
Published: (2023-12-01)

Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism
by: Guangjie Zhao, et al.
Published: (2021-09-01)

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia
by: Alexander J. Ambinder, et al.
Published: (2022-10-01)

Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Kah Keng Wong, et al.
Published: (2021-02-01)

Salvage Therapy after Allogeneic Hematopoietic Cell Transplantation: Targeted and Low-Intensity Treatment Options in Myelodysplastic Syndrome and Acute Myeloid Leukemia
by: Katie Culos, et al.
Published: (2019-05-01)

A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome
by: Wei Guoqing, et al.
Published: (2011-11-01)

Gingival enlargement in myelodysplastic syndrome
by: Navia George, et al.
Published: (2015-01-01)

Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival
by: Giulia Corradi, et al.
Published: (2018-10-01)

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation
by: Edward Abadir, et al.
Published: (2019-10-01)

New SAMD9L heterozygous mutation leading to myelodysplastic syndrome and acute myeloid leukemia: A case report and review of the literature
by: Dania A. Monagel
Published: (2023-04-01)

The Role of T Cell Immunotherapy in Acute Myeloid Leukemia
by: Fang Hao, et al.
Published: (2021-12-01)

Jumping translocations of chromosome 1q occurring by a multi-stage process in an acute myeloid leukemia progressed from myelodysplastic syndrome with a TET2 mutation
by: Ina Lee, et al.
Published: (2019-11-01)

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
by: Pimjai Niparuck, et al.
Published: (2021-10-01)

Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer
by: Yufeng Shang, et al.
Published: (2019-09-01)

Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia
by: Uy N, et al.
Published: (2018-04-01)

Laboratory diagnostics stages of myelodysplastic syndrome transformation into acute erythroid leukemia (clinical case report)
by: I. E. Volgina
Published: (2022-01-01)

Association between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia
by: Wei Qiao, et al.
Published: (2022-09-01)

Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and Beyond
by: Rebecca Epperly, et al.
Published: (2020-02-01)

Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges
by: Yuhang Xue, et al.
Published: (2024-02-01)

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Fernando Vieira Pericole, et al.
Published: (2019-01-01)

Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia: First Cousins or Unrelated Entities?
by: Romane Joudinaud, et al.
Published: (2021-08-01)

The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia
by: Sarah Weber, et al.
Published: (2021-02-01)

Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia
by: Hui Zhang, et al.
Published: (2020-05-01)